nimodipine has been researched along with Critical Illness in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients suffering from critical illnesses like cardiac arrest with resuscitation and hypovolemic shock often are in need of medication." | 2.41 | [Pharmacology in critical illness]. ( Buylaert, WA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buylaert, WA | 1 |
1 review available for nimodipine and Critical Illness
| Article | Year |
|---|---|
[Pharmacology in critical illness].
Topics: Adrenergic Agonists; Anesthetics, Intravenous; Animals; Calcium Channel Blockers; Cardiopulmonary Re | 2001 |